Notification

No new Notification messages

Pre-Apply for Manba Finance IPO
Don't miss out on the latest IPOs! Use Bajaj Broking's Pre-Apply feature.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
Trade Now, Pay Later with up to 4x Leverage
Never miss a good trading opportunity due to low funds with our MTF feature.

Senores Pharmaceuticals Limited

-

Offer Period :

Lorem ipsum dolor sit amet consectetur. Auctor nunc ipsum vel ultricies et proin commodo vestibulum. Egestas nulla sollicitudin gravida eu adipiscing vitae ut eu. Scelerisque sagittis integer quisque nibh in sem. Read more... Lorem ipsum dolor sit amet consectetur. Auctor nunc ipsum vel ultricies et proin commodo vestibulum. Egestas nulla sollicitudin gravida eu adipiscing vitae ut eu. Scelerisque sagittis integer quisque nibh in sem.Read less

Senores Pharmaceuticals Limited IPO Details

IPO Date - Minimum Investment ₹ / Lots
Listing Date Maximum Investment ₹ / Lots
Face Value ₹0 per share Total Issue Size ₹0 Crores
Price ₹0 to ₹0 per share Fresh Issue ₹0 Crores
Lot Size 1 Lots (0 Shares) Offer For Sale ₹ 0
Listing At Retail Discount ₹ 0
Employee Discount ₹0 per share    
IPO Date -
Listing Date
Face Value ₹0 per share
Price ₹0 to ₹0 per share
Lot Size 1 Lots (0 Shares)
Listing At
Employee Discount ₹0 per share
Minimum Investment ₹ / Lots
Maximum Investment ₹ / Lots
Total Issue Size ₹0 Crores
Fresh Issue ₹0 Crores
Offer For Sale
Retail Discount ₹ 0

Timeline

Important dates for allocation and IPO listing.

-

IPO Starts

-

IPO Ends

-

Allotment Date

-

Initiation of Refund

-

Credit of Shares to Demat Account

-

IPO Listing Date

Shareholder Pattern

  Pre-Issue Post-Issue
Promoter Group 0 0
Public Group 0 0

Senores Pharmaceuticals Limited IPO Reservation

QIB Shares Offered 0(0%)
NII (HNI) Shares Offered 0(0%)
Retail Shares Offered 0(0%)
Anchor Investor Shares Offered 0(0%)
Total Shares Offered 0
Total Shares With Anchor Investor 0

IPO Lot Size

ApplicationLotsSharesAmount
Retail (Min)---
Retail (Max)---
S-HNI (Min)---
S-HNI (Max)---

Senores Pharmaceuticals Limited IPO Registrar

Link Intime India Pvt Ltd
Phone Number +91 8108114949
Email Id senorespharma.ipo@linkintime.co.in
Our Website www.linkintime.co.in

Senores Pharmaceuticals Limited IPO Lead Manager

1. Equirus Capital Pvt Ltd

2. Ambit Pvt Ltd

3. Nuvama Wealth Management Ltd

Explore IPOs


Explore comprehensive IPO details for every IPO. Access essential information such as listing price, listing date, issue price, lot size, issue size, minimum investment, and IPO timeline. Gain insights into the company's background, strengths, and potential risks. Track the subscription status and delve into the financials of the company, empowering yourself with crucial data for informed investment decisions. Stay ahead in the dynamic IPO market by staying informed on upcoming, ongoing, and past IPOs. 
 

Stay ahead in the ever-evolving IPO landscape with our comprehensive platform. We offer a holistic resource, ensuring you not only access essential details but also gain valuable insights into market trends. Navigate confidently, armed with intricate analyses, expert opinions, and real-time updates. Whether you're a seasoned investor or a novice, our user-friendly interface and extensive information empower you to make well-informed decisions. Experience the convenience of having a dedicated space where you can delve into the intricacies of IPOs, enabling a strategic and calculated approach to the dynamic stock market. 

Senores Pharmaceuticals Limited IPO Subscription LIVE Status

Category No. of shares offered No. of shares bid No. of subscribed

Strength of Senores Pharmaceuticals Limited

1. Ability to cater to the Regulated Markets through our US FDA approved formulation manufacturing facility in the US.

2. Distinct niche product portfolio built in a short span for Regulated Markets.

3. Long-term marketing arrangements with pharmaceutical companies in the Regulated Markets.

4. Presence in the Emerging Markets with a strong product portfolio, including specialty or complex products.

5. Strong R&D capabilities driving our differentiated portfolio of products.

6. Professional and dedicated management teams for our diverse business verticals.

Risks Involved

1. Our business is dependent on the sale of our products through third party marketing partners and distributors. The loss of one or more marketing partners or distributors, the deterioration of their financial condition or prospects, or a reduction in their demand for our products or our inability to maintain and increase the number of our arrangements for the marketing and distribution of our products could adversely affect our business, results of operations, financial conditions and cash flows.

2. We are subject to strict technical specifications, quality requirements, regular inspections and audits by our customers. Our failure to comply with the quality standards and technical specifications prescribed by such customers may lead to loss of business from such customers and could negatively impact our business, results of operations and financial condition, including cancellation of existing and future orders which may expose us to warranty claims.

3. We derive a significant part of our revenue from few customers. If one or more of such customers choose not to source their requirements from us or to terminate our contracts or purchase orders, our business, cash flows, financial condition and results of operations may be adversely affected.

4. The pharmaceutical market is subject to extensive regulation and failures to comply with the existing and future regulatory requirements in any pharmaceutical market could expose us to litigation or other liabilities, which could adversely affect our reputation, business, financial condition and results of operations.

5. We derive a significant portion of our revenue from our operations in the United States. A reduction in demand for our products in these regions could adversely affect our business, results of operations, financial conditions and cash flows.

6. Any manufacturing or quality control problems may damage our reputation for high quality production and expose us to potential litigation or other liabilities, which would negatively impact our business, prospects, results of operations and financial condition.

7. Under-utilization of our manufacturing capacities and an inability to effectively utilize our expanded manufacturing capacities could have an adverse effect on our business, future prospects and future financial performance.

8. We depend on a limited number of contract development and manufacturing organization ("CDMO") and contract manufacturing operations ("CMO") customers both in Regulated Markets and Emerging Markets. Any adverse developments or inability to enter into or maintain relationships with these CDMO customers could have an adverse effect on our business, results of operations and financial condition.

9. We have a limited operating history which may make it difficult for investors to assess our future growth prospects and business.

10. Our business is working capital intensive. If we are unable to borrow to meet our working capital requirements, it may materially and adversely affect our business and results of operations.

Why should you invest in

-

Financials

Particulars For the financial year ending (in ₹ million)
  2024 2023 2022
Total Assets 621.88 131.05 59.15
Total Liabilities 621.88 131.05 59.15
Total Expenses 192.4 26.58 13.49
Total Revenue 
217.34 39.02 14.63
Profit After Tax 31.45 8.43 0.99
EBITDA 44.41 16.35 2.41
Adjusted EBITDA 0 0 0

Senores Pharmaceuticals Limited IPO Listing Details

Listing Date BSE Script Code NSE Symbol ISIN Final Issue Price
0 -
INE0RB801010
₹0 per share

Listing Day Trading Information

Price Details BSE NSE
Final Issue Price ₹0 ₹0
Open ₹0 ₹0
Low ₹0 ₹0
High ₹0 ₹0
Low ₹0 ₹0

Frequently Asked Questions

What is Senores Pharmaceuticals Limited IPO?

Answer Field

Senores Pharmaceuticals Limited IPO is a [-] IPO of [-] equity shares of a face value of ₹[-] aggregating up to ₹[-] Crores. The issue is priced at ₹[-] to ₹[-] per share. The minimum order quantity is [-] Shares. The IPO opens on [-], and closes on [-]. Link Intime India Pvt Ltd is the registrar for the IPO. The shares are proposed to be listed on [-].

When Senores Pharmaceuticals Limited IPO will open?

Answer Field

The Senores Pharmaceuticals Limited IPO opens on [-] and closes on [-].

What is the lot size of Senores Pharmaceuticals Limited?

Answer Field

Senores Pharmaceuticals Limited lot size is [-] shares, and the minimum amount required is ₹[-].

How to apply for Senores Pharmaceuticals Limited IPO?

Answer Field

You can apply in Senores Pharmaceuticals Limited IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. To apply for an IPO:

• Login to Bajaj Broking account App/Website & click on IPO

• Enter the number of lots and price at which you wish to apply.

• Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.

• You will receive a mandate notification to block funds in your UPI app.

• Approve the mandate request on your UPI and funds will be blocked.

When is Senores Pharmaceuticals Limited IPO allotment?

Answer Field

The finalization of Basis of Allotment for Senores Pharmaceuticals Limited IPO will be done on [-], and the allotted shares will be credited to your demat account by [-].

When is Senores Pharmaceuticals Limited IPO listing date?

Answer Field

The Senores Pharmaceuticals Limited listing date is [-].

Who is the registrar of Senores Pharmaceuticals Limited IPO?

Answer Field

The registrar of Senores Pharmaceuticals Limited IPO is Link Intime India Pvt Ltd

Which company is the book-running lead manager of the IPO?

Answer Field

Equirus Capital Pvt Ltd,Ambit Pvt Ltd,Nuvama Wealth Management Ltd will be the book-running lead manager of this IPO.

What is the fresh issue of Senores Pharmaceuticals Limited IPO?

Answer Field

The fresh issue size is ₹[-] Crores equity shares.

What minimum lot size can retail subscribers subscribe to Senores Pharmaceuticals Limited?

Answer Field

Retail investors can subscribe to a minimum of one lot, [-] shares and ₹[-] amount.

How can I approve the UPI mandate request for Senores Pharmaceuticals Limited IPO?

Answer Field

To apply for Senores Pharmaceuticals Limited IPO, you need to log in to your demat account to complete the bidding process. Then, approve the payment mandate on your UPI app.

What is the price range of Senores Pharmaceuticals Limited?

Answer Field

The price of each Senores Pharmaceuticals Limited share will be ranging in between ₹[-] to ₹[-] per share.

What is the cut-off time for the UPI mandate for Senores Pharmaceuticals Limited IPO?

Answer Field

The cut-off time for the UPI mandate confirmation is 5:00 PM, [-].

No results found

Browse IPOs

upcoming-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
  • Lorem Ipsum
current-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
  • Lorem Ipsum
  • KALANA ISPAT LIMITEDSME IPO

  • Bidding Dates

    19th Sep 2024 - 9th Sep 2024

  • Price Range

    ₹66 - 66

  • IPO Size

    ₹32,59,00,000

  • Apply Now
  • PHOENIX OVERSEAS LIMITEDSME IPO

  • Bidding Dates

    20th Sep 2024 - 9th Sep 2024

  • Price Range

    ₹61 - 64

  • IPO Size

    ₹36,03,00,000

  • Apply Now
  • AVI ANSH TEXTILE LIMITEDSME IPO

  • Bidding Dates

    20th Sep 2024 - 9th Sep 2024

  • Price Range

    ₹62 - 62

  • IPO Size

    ₹26,00,00,000

  • Apply Now
  • BIKEWO GREEN TECH LIMITEDSME IPO

  • Bidding Dates

    20th Sep 2024 - 9th Sep 2024

  • Price Range

    ₹59 - 62

  • IPO Size

    ₹24,09,00,000

  • Apply Now
  • S D RETAIL LIMITEDSME IPO

  • Bidding Dates

    20th Sep 2024 - 9th Sep 2024

  • Price Range

    ₹124 - 131

  • IPO Size

    ₹64,98,00,000

  • Apply Now
  • WOL 3D INDIA LIMITEDSME IPO Early Access

  • Bidding Dates

    23rd Sep 2024 - 9th Sep 2024

  • Price Range

    ₹142 - 150

  • IPO Size

    ₹25,56,00,000

  • Apply Now
  • RAPPID VALVES INDIA LIMITEDSME IPO Early Access

  • Bidding Dates

    23rd Sep 2024 - 9th Sep 2024

  • Price Range

    ₹210 - 222

  • IPO Size

    ₹30,41,00,000

  • Apply Now
  • MANBA FINANCE LIMITEDMainboard IPO Early Access

  • Bidding Dates

    23rd Sep 2024 - 9th Sep 2024

  • Price Range

    ₹114 - 120

  • IPO Size

    ₹6,03,00,00,000

  • Apply Now
closed-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
  • Lorem Ipsum
  • PELATRO LIMITEDSME IPO

  • Bidding Dates

    16th Sep 2024 - 9th Sep 2024

  • Price Range

    ₹190 - 200

  • IPO Size

    ₹55,98,00,000

  • Invest Now
  • KROSS LIMITEDMainboard IPO

  • Bidding Dates

    9th Sep 2024 - 9th Sep 2024

  • Price Range

    ₹228 - 240

  • IPO Size

    ₹5,00,00,00,000

  • Invest Now
performance-radio
  • IPO Name
  • ISSUE PRICE
  • LISTING DAY CLOSE
  • LISTING DAY(GAIN/LOSS)
  • Lorem Ipsum
  • EXCELLENT WIRES AND PACKAGING LIMITEDSME IPO

  • Issue Price

    90.00

  • Listing Day Close

    82.05

  • Listing Day (Gain/Loss)

    -8.89

  • INNOMET ADVANCED MATERIALS LIMITEDSME IPO

  • Issue Price

    100.00

  • Listing Day Close

    199.50

  • Listing Day (Gain/Loss)

    100.00

  • P N GADGIL JEWELLERS LIMITEDMainboard IPO

  • Issue Price

    480.00

  • Listing Day Close

    792.80

  • Listing Day (Gain/Loss)

    65.21

  • SPP POLYMER LIMITEDSME IPO

  • Issue Price

    59.00

  • Listing Day Close

    59.85

  • Listing Day (Gain/Loss)

    1.69

  • TOLINS TYRES LIMITEDMainboard IPO

  • Issue Price

    226.00

  • Listing Day Close

    238.30

  • Listing Day (Gain/Loss)

    5.31

  • GAJANAND INTERNATIONAL LIMITEDSME IPO

  • Issue Price

    36.00

  • Listing Day Close

    39.90

  • Listing Day (Gain/Loss)

    11.11

  • KROSS LIMITEDMainboard IPO

  • Issue Price

    240.00

  • Listing Day Close

    259.50

  • Listing Day (Gain/Loss)

    8.33

  • SHUBHSHREE BIOFUELS ENERGY LIMITEDSME IPO

  • Issue Price

    119.00

  • Listing Day Close

    198.45

  • Listing Day (Gain/Loss)

    66.39

  • BAJAJ HOUSING FINANCE LIMITEDMainboard IPO

  • Issue Price

    70.00

  • Listing Day Close

    164.99

  • Listing Day (Gain/Loss)

    135.71

  • ADITYA ULTRA STEEL LIMITEDSME IPO

  • Issue Price

    62.00

  • Listing Day Close

    66.40

  • Listing Day (Gain/Loss)

    6.45

  • SHARE SAMADHAN LIMITEDSME IPO

  • Issue Price

    74.00

  • Listing Day Close

    74.87

  • Listing Day (Gain/Loss)

    1.35

  • VISION INFRA EQUIPMENT SOLUTIONS LIMITEDSME IPO

  • Issue Price

    163.00

  • Listing Day Close

    215.25

  • Listing Day (Gain/Loss)

    31.90

  • MY MUDRA FINCORP LIMITEDSME IPO

  • Issue Price

    110.00

  • Listing Day Close

    123.50

  • Listing Day (Gain/Loss)

    12.73

  • MACH CONFERENCES AND EVENTS LIMITEDSME IPO

  • Issue Price

    225.00

  • Listing Day Close

    295.55

  • Listing Day (Gain/Loss)

    31.56

  • NAMO EWASTE MANAGEMENT LIMITEDSME IPO

  • Issue Price

    85.00

  • Listing Day Close

    169.55

  • Listing Day (Gain/Loss)

    100.00

  • NATUREWINGS HOLIDAYS LIMITEDSME IPO

  • Issue Price

    74.00

  • Listing Day Close

    90.25

  • Listing Day (Gain/Loss)

    21.62

  • JEYYAM GLOBAL FOODS LIMITEDSME IPO

  • Issue Price

    61.00

  • Listing Day Close

    64.05

  • Listing Day (Gain/Loss)

    4.92

  • GALA PRECISION ENGINEERING LIMITEDMainboard IPO

  • Issue Price

    529.00

  • Listing Day Close

    787.05

  • Listing Day (Gain/Loss)

    48.77

  • BAAZAR STYLE RETAIL LIMITEDMainboard IPO

  • Issue Price

    389.00

  • Listing Day Close

    399.65

  • Listing Day (Gain/Loss)

    2.83

  • BOSS PACKAGING SOLUTIONS LIMITEDSME IPO

  • Issue Price

    66.00

  • Listing Day Close

    86.60

  • Listing Day (Gain/Loss)

    31.82

We have something for everyone

Explore more Investment options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Related Articles

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7.5 Lacs + Users

icon-with-text

4.8+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4800 Cr MTF Book

icon-with-text